Press Releases

News, Events, Updates, Breakthroughs

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Mon Nov 07 00:00:00 GMT-05:00 2016
Daiichi Sankyo Announces New Subgroup Analyses of Once-Daily SAVAYSA® (edoxaban) in Patients with N ...
PDF (367 KB)
Tue Oct 25 00:00:00 GMT-05:00 2016
Anti-HER3 Monoclonal Antibody Patritumab Selected for I-SPY 2 TRIAL in Breast Cancer
PDF (143 KB)
Tue Oct 25 00:00:00 GMT-05:00 2016
Daiichi Sankyo, Inc. and Inspirion Delivery Sciences LLC Announce U.S. Licensing Agreement for Morp ...
PDF (349 KB)
Fri Oct 21 00:00:00 GMT-05:00 2016
ENLIVEN Phase 3 Study of Pexidartinib in Tenosynovial Giant Cell Tumor (TGCT) Will Continue to Comp ...
PDF (161 KB)
Wed Oct 12 00:00:00 GMT-05:00 2016
Daiichi Sankyo and Dana-Farber Cancer Institute Announce Lung Cancer Research Collaboration
PDF (135 KB)
Tue Oct 11 00:00:00 GMT-05:00 2016
Daiichi Sankyo Announces First Patient Enrolled in Phase 3 QuANTUM-First Trial Investigating Quizar ...
PDF (163 KB)
Sun Oct 09 00:00:00 GMT-05:00 2016
Daiichi Sankyo Presents Late-Breaking Phase 1 Data for Novel Investigational HER2-Targeting Antibod ...
PDF (172 KB)
Tue Oct 04 00:00:00 GMT-05:00 2016
Daiichi Sankyo Announces New Strategic Immuno-Oncology Research Collaboration with AgonOx
PDF (223 KB)
Wed Sep 28 00:00:00 GMT-05:00 2016
Zymeworks and Daiichi Sankyo Announce Immuno-Oncology Cross-Licensing Agreement and Bi-Specific Ant ...
PDF (179 KB)
Tue Sep 27 00:00:00 GMT-05:00 2016
Daiichi Sankyo to Present at ESMO 2016 Late-Breaking Clinical Data for Novel HER2-Targeting Antibod ...
PDF (152 KB)
Showing 1 - 10 of 22 results.